Cryoballoon treatment for intermittent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a procedure called cryoballoon ablation that freezes the tissue causing irregular heartbeats. It is for people with intermittent atrial fibrillation who have not had this procedure before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with paroxysmal (intermittent) atrial fibrillation.
- You have not had a previous heart ablation or other procedure on the left atrium.
- Your heart is functioning well enough (no severe valve disease, ejection fraction above 40%).
- You have not had a stroke, heart attack, or heart surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new cryoablation system that uses freezing to treat paroxysmal atrial fibrillation, a type of irregular heartbeat that comes and goes. It aims to restore a normal heart rhythm and improve symptoms.
This trial tests a new catheter-based treatment for paroxysmal atrial fibrillation (AF) — a type of irregular heartbeat that comes and goes. It uses a special balloon catheter to deliver energy to the heart to help restore a normal rhythm. This may be an option if medications haven't controlled your symptoms.
This study tests a new approach to a common procedure for atrial fibrillation (AFib) called pulmonary vein isolation. It uses a single-shot cryoablation technique to treat people with paroxysmal or persistent AFib.
This study tests a new balloon catheter that uses pulsed electric fields to isolate the veins that carry blood from your lungs to your heart. It may be a treatment option for people with atrial fibrillation who are scheduled for an ablation procedure.
This trial tests a new treatment that uses two types of energy (pulsed field and radiofrequency) to fix the heart's electrical signals in people with paroxysmal atrial fibrillation (AFib that comes and goes). It aims to be more effective and safer than standard ablation alone.
This study compares two heart procedures to treat atrial fibrillation in people who also have valve disease. One is a standard approach and the other adds a bit more treatment to try to prevent the arrhythmia from coming back.
Hear when a new Paroxysmal Atrial Fibrillation (PAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.